We are live on ! Find out more
TNDM icon

Tandem Diabetes Care
TNDM

46 hedge funds and large institutions have $28M invested in Tandem Diabetes Care in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 15 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more capital invested

Capital invested by funds: $14.7M → $28M (+$13.3M)

0.53% less ownership

Funds ownership: 3.69% → 3.16% (-0.53%)

27% less funds holding

Funds holding: 63 → 46 (-17)

33% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 15

71% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 24

Holders
46
Holders Change
-17
Holders Change %
-26.98%
% of All Funds
1.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
10
Reduced
15
Closed
24
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$154K
2
SKK
Shepherd Kaplan Krochuk
Massachusetts
+$115K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$107K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$102K
5
VF
Virtu Financial
New York
+$63K

Top Sellers

Rank Fund Capital Flow
1
DCM
DAFNA Capital Management
California
-$579K
2
PC
Paulson & Co
New York
-$400K
3
Bank of America
Bank of America
North Carolina
-$314K
4
FPC
Falcon Point Capital
California
-$209K
5
RPAM
Rhenman & Partners Asset Management
Sweden
-$187K
Name Holding Trade Value Shares
Change 		Change in
Stake
GC
26
Guggenheim Capital
Illinois
$12K +$10.4K +1,650 New
CG
27
Cutler Group
California
$11K -$3.23K -510 -24%
RJA
28
Raymond James & Associates
Florida
$11K – – –
Stifel Financial
29
Stifel Financial
Missouri
$10K +$633 +100 +7%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$9K – – –
Ameriprise
31
Ameriprise
Minnesota
$7K -$6 -1 -0.1%
Citigroup
32
Citigroup
New York
$7K – – –
Wells Fargo
33
Wells Fargo
California
$6K +$4.04K +639 +456%
Federated Hermes
34
Federated Hermes
Pennsylvania
$3K -$1.69K -267 -37%
Bank of America
35
Bank of America
North Carolina
$2K -$314K -49,605 -100%
Royal Bank of Canada
36
Royal Bank of Canada
Ontario, Canada
$2K -$4.74K -748 -73%
RWA
37
Ropes Wealth Advisors
Massachusetts
$2K – – –
MAM
38
Meeder Asset Management
Ohio
$2K +$1.06K +168 +185%
UBS Group
39
UBS Group
Switzerland
$1K -$7.25K -1,145 -87%
AG
40
Advisor Group
Arizona
$1K – – –
PCM
41
Prelude Capital Management
New York
$1K +$487 +77 New
BNP Paribas Financial Markets
42
BNP Paribas Financial Markets
France
$23 – – –
DCM
43
DAFNA Capital Management
California
– -$579K -72,429 Closed
PC
44
Paulson & Co
New York
– -$400K -50,000 Closed
FPC
45
Falcon Point Capital
California
– -$209K -26,141 Closed
RPAM
46
Rhenman & Partners Asset Management
Sweden
– -$187K -23,400 Closed
ECM
47
Element Capital Management
New York
– -$130K -16,246 Closed
SI
48
Shaker Investments
Ohio
– -$112K -13,956 Closed
PP
49
Paloma Partners
Connecticut
– -$84K -10,548 Closed
Millennium Management
50
Millennium Management
New York
– -$82K -10,194 Closed
1
2
3

TNDM Hedge Fund Activity: Q3 2017 in Review

46 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q3 2017, worth a combined $28M — up 90% from $14.7M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of TNDM and 7 opened new positions — a net loss of 17 holders — while 15 trimmed existing stakes and 10 added.

The largest buyer was BlackRock, adding an estimated $154K. The largest seller was DAFNA Capital Management, exiting entirely with an estimated $579K sold.

  • 46 institutional investors held Tandem Diabetes Care (TNDM) as of Q3 2017, down from 63 in Q2 2017.
  • Funds reported $28M of Tandem Diabetes Care stock for Q3 2017, up 90% quarter-over-quarter.
  • 7 funds opened new Tandem Diabetes Care positions in Q3 2017 and 24 closed out, a net change of -17 holders.
  • The largest Tandem Diabetes Care buyer in Q3 2017 was BlackRock, an estimated $154K added.
  • The largest Tandem Diabetes Care seller in Q3 2017 was DAFNA Capital Management, an estimated $579K sold.

Based on aggregated 13F filings for Q3 2017.